Cargando…
Combinations of Drugs in the Treatment of Obesity
Obesity is a chronic disease associated with excess morbidity and mortality. Clinical treatment, however, currently offers disappointing results, with very high rates of weight loss failure or weight regain cycles, and only two drugs (orlistat and sibutramine) approved for long-term use. Drugs combi...
Autores principales: | Halpern, Bruno, Oliveira, Eduardo S. L., Faria, André M., Halpern, Alfredo, de Melo, Maria Edna, Cercato, Cintia, Mancini, Marcio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033931/ https://www.ncbi.nlm.nih.gov/pubmed/27713360 http://dx.doi.org/10.3390/ph3082398 |
Ejemplares similares
-
The new obesity classification based on weight history is not proposed as a guideline
por: Halpern, Bruno, et al.
Publicado: (2022) -
Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO)
por: Halpern, Bruno, et al.
Publicado: (2022) -
Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008) -
Efficacy and Tolerability of the Association of Sibutramine and
Orlistat for Six Months in Overweight and Obese Patients
por: Halpern, Alfredo, et al.
Publicado: (2010) -
Genetic Variations in Sweet Taste Receptor Gene Are Related to Chocolate Powder and Dietary Fiber Intake in Obese Children and Adolescents
por: Pioltine, Marina B., et al.
Publicado: (2018)